Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
igy (1 trial)
insulin human (humulin) (1 trial)
repaglinide (prandin) (1 trial)
glutathione (Furadantin) (1 trial)
Cystic Fibrosis (Phase 3)
Diabetes Mellitus (Phase 3)
Fibrosis (Phase 3)
Pseudomonas Infections (Phase 3)
Trials (3 total)
Trial APIs (4 total)